Merrion Pharma to raise funds to develop products

Company has already raised $24m and now hopes to develop drug delivery technology through flotation, writes Gavin Daly.

7th April, 2007

Company has already raised $24m and now hopes to develop drug delivery technology through flotation, writes Gavin Daly.

Merrion Pharmaceuticals, the Dublin Firm that plans to list in Ireland and the US next month, is betting on investor interest in the potential of its drugs.

The company has a limited trading history, with turnover of just over $200,000 (€150,000) from the time it was founded in December 2003 to the end of September last year.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago